EP1389911A1 — Ectoparasiticidal compositions and methods of their use
Assigned to Medicis Pharmaceutical Corp · Expires 2004-02-25 · 22y expired
What this patent protects
The present invention provides compositions and methods for killing mammalian ectoparasites and eggs. The present invention provides compositions comprising active ingredients, such as, for example, terpenes, such as dipentene and/or D- limonene; and/or terpene-ols, such as, for …
USPTO Abstract
The present invention provides compositions and methods for killing mammalian ectoparasites and eggs. The present invention provides compositions comprising active ingredients, such as, for example, terpenes, such as dipentene and/or D- limonene; and/or terpene-ols, such as, for example, terpineol and 1-terpinen-4-ol; and/or 1,2,3,4-tetrahydronaphthalene; and/or aromatic alcohols; and/or essential oils. The present invention also provides, compositions and methods for killing mammalian ectoparasites and eggs which are resistant to ingredient(s) in established insecticides, such as for example, malathion, permethrin and/or lindane.
Drugs covered by this patent
- Ovide (MALATHION) · Taro
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.